Join me and my co-chairs at #MedtechMVP this June 20-21 in Minneapolis! View the final agenda and register now to join us:
https://t.co/5Q8wDePjfa. Use the discount code to save 10%, and register by May 19th to save another $100!
#medtech#innovation#medtech
Abiomed has acquired preCARDIA, developer of a proprietary catheter & controller system uniquely designed to rapidly treat volume overload & address ADHF by effectively reducing cardiac filling pressures & supporting decongestion. Learn more: https://t.co/RxxtfT4RjY
Looking forward to a robust series of presentations and discussions focused on the physiology, science, medicine, and business of Device innovations for acute and chronic Heart Failure. Join us for D-HF on a virtual platform this year! @BurkhoffMd
https://t.co/fjI3DQ0vBi
So honored to have @PrecardiaInc included on the list. I am proud of the passion and hard work of our team, investigators, coordinators, advisors and partners as we continue to advance our novel device designed to treat patients suffering from acute decompensated heart failure.
Innovation Shark-Tank #TCTConnect starts today (11:00-AM EST @ Innovation Channel). 3 technologies will present today and 3 tomorrow. Please vote for your favorite as they are presented! @TCTConference@JHDHFoundation
This is the last one of this series and it deserves additional explanation; preCardia it is a proprietary SVC Balloon mounted on a PA Catheter + Pump and Console to deliver a Programmed Duty Cycle and Monitor Right Atrial and Jugular Venous Pressures as a therapy for HF pts.
"One thing our conference has done so well is bring multiple players across the healthcare system together," says May 31 Medtech Conference co-chair Stacy Enxing Seng. Join the conversation & participate today - https://t.co/55L7B0UAoV #Medtech#Investing#innovation